Submission Details
| 510(k) Number | K200741 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 23, 2020 |
| Decision Date | March 31, 2020 |
| Days to Decision | 8 days |
| Submission Type | Traditional |
| Review Panel | Gastroenterology & Urology (GU) |
| Summary | Summary PDF |
K200741 is an FDA 510(k) clearance for the Tablo Hemodialysis System, a Dialyzer, High Permeability With Or Without Sealed Dialysate System (Class II — Special Controls, product code KDI), submitted by Outset Medical, Inc. (San Jose, US). The FDA issued a Cleared decision on March 31, 2020, 8 days after receiving the submission on March 23, 2020. This device falls under the Gastroenterology & Urology review panel. Regulated under 21 CFR 876.5860.
| 510(k) Number | K200741 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 23, 2020 |
| Decision Date | March 31, 2020 |
| Days to Decision | 8 days |
| Submission Type | Traditional |
| Review Panel | Gastroenterology & Urology (GU) |
| Summary | Summary PDF |
| Product Code | KDI — Dialyzer, High Permeability With Or Without Sealed Dialysate System |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 876.5860 |